Executive summary: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).
about
Factor Xa inhibitors for acute coronary syndromesTooth extraction in patients on oral anticoagulants: prospective study conducted in 108 brazilian patientsEpidemiology and pathophysiology of nephrotic syndrome-associated thromboembolic diseaseRheolytic Thrombectomy with or without Adjunctive Indwelling Pharmacolysis in Patients Presenting with Acute Pulmonary Embolism Presenting with Right Heart Strain and/or Pulseless Electrical Activity.Review: recent advances in argatroban-warfarin transition in patients with heparin-induced thrombocytopenia.Acute bioprosthetic mitral valve stenosis in a patient with HITS.Primary thromboprophylaxis in the palliative care setting: a qualitative systematic review.A team-based approach to warfarin management in long term care: a feasibility study of the MEDeINR electronic decision support system.Comparison of pharmacist managed anticoagulation with usual medical care in a family medicine clinicBurden of disease from atrial fibrillation in adults from seven countries in Latin America.Historical lessons in translational medicine: cyclooxygenase inhibition and P2Y12 antagonism.73-Year-old woman with anterior thigh pain.Effect of a combined anti-thrombotic therapy of thrombosis on prosthetic heart valves.A systematic review on comparing 2 common models for management of warfarin therapy; pharmacist-led service versus usual medical care.Stroke and Bleeding Risk Associated With Antithrombotic Therapy for Patients With Nonvalvular Atrial Fibrillation in Clinical PracticeThe development of evidence-based care recommendations to improve the safe use of anticoagulants in children.Impact of genetic polymorphisms on clinical response to antithrombotics.Impact of Point-of-Care Implementation in Pharmacist-Run Anticoagulation Clinics Within a Community-Owned Health System: A Two-Year Retrospective AnalysisPharmacogenetic testing: Current Evidence of Clinical Utility.The prevention and treatment of venous thromboembolism with LMWHs and new anticoagulants.New generation aspiration catheter: Feasibility in the treatment of pulmonary embolism.Safety and tolerability of antiplatelet therapies for the secondary prevention of atherothrombotic disease.Fibrinolytic therapy of prosthetic mitral valve thrombosis during pregnancy: three case reports and review of the literature.Pulmonary thromboembolic disease spectrum: diagnostic and therapeutic strategies.Implementation of pharmacist-managed anticoagulation clinic in a saudi arabian health center.Venous thromboembolism: a clinical review.Comparison of two different models of anticoagulation management services with usual medical care.Role of warfarin pharmacogenetic testing in clinical practice.Novel oral anticoagulants. Part II: direct thrombin inhibitors.Novel oral anticoagulants for prophylaxis and treatment of venous thromboembolism: part I (Factor Xa inhibitors).The surgical management of chronic subdural hematoma.An imaging approach to deep vein thrombosis and the lower extremity thrombosis classification.Cardiac risks and management of complications in pregnant women with congenital heart disease.Primary prevention of venous thromboembolism.Use of the chromogenic factor X assay in patients transitioning from argatroban to warfarin therapy.Anticoagulant use in real time.New Oral Anticoagulants: How Do We Use Them Wisely?Inferior Vena Cava Filters: Guidelines, Best Practice, and Expanding Indications.Massive pulmonary embolism associated with Factor V Leiden, prothrombin, and methylenetetrahydrofolate reductase gene mutations in a young patient on oral contraceptive pills: a case report.Optimization of vitamin K antagonist drug dose finding by replacement of the international normalized ratio by a bidirectional factor: validation of a new algorithm.
P2860
Q24234760-97979AD1-9DE6-409E-B357-4ADC7EF61C1FQ24601050-6E1769E0-996D-4CB6-B93F-59C773209430Q26999284-87CC17B2-1646-400C-B81A-E0CAD420ABABQ30428777-1299EE4F-D736-4879-8B72-79E9FC6FE3B1Q33382275-C88144A7-5226-442E-A6B9-B5DDD82073CCQ33395238-65BC056E-A395-4F30-B2BB-2DFECD76B5B6Q33548617-B63330DF-D5A6-4837-AE4C-35EDC6F82B3FQ33600407-51276E02-E721-4EEE-B182-63C8EC7857E8Q33995194-7DBEE200-C18F-4572-91FA-8BDCF0A4D1BCQ34156117-B3A1E7D5-D1E9-405E-BFB3-5C426DC660ABQ34536091-9B9DDA96-B502-4D2E-823C-61A2A7453432Q34748526-BAE62FED-29E7-4BD0-AADA-245E35CECA14Q35290356-EE228BA5-0EAC-45CF-BBCB-19A7A616D32CQ35671241-86C2FFE0-D28B-4945-809B-06FC76B36D71Q36168742-220250B2-C3C3-424B-9E45-8324D912FB87Q36314654-6FCF98D6-48FB-4A62-A884-A42C37E070BBQ36441477-D6C35DB6-79E3-4F6D-A80C-2627673451A9Q36572418-6A623EAB-79A1-4B33-A393-48F48DE18D2DQ37151528-A5A90F81-0C3B-49FD-8896-3BD4803EB389Q37316352-3A74F62C-0CA7-4031-ABD3-9C7ED11D1B9AQ37376170-9238FBA5-FA18-4C00-8C3D-09B75EE80402Q37532491-D3EA721C-953E-40CB-9FE5-D82A43979C9EQ37614068-37AE697C-321E-402A-9341-4BCB38425B25Q37629849-20A25B8B-EE22-47B4-BCCD-DC0432B51F56Q37676340-8C222A35-3E59-44B8-A580-3AB0B11F3EECQ37702728-0F258D71-A21A-4582-B5CB-E2BA611EEB09Q37718222-4AF13421-1C54-4AFB-9A6C-1ABE91CEE206Q37733582-84032271-E316-42B6-B8F1-AFC2136A4C38Q37810102-483142AE-E8D8-466F-9DD6-BC30BA94AC25Q37810274-CE167BC8-CC47-4852-A2CB-A54F64053F63Q37930462-4206A5B4-C514-4984-AFD4-2F0C8D84DBA3Q37982041-97A519CF-7EDD-4F90-8AB3-9F7C07A1D09AQ37993154-63DC81B6-1F36-4E6B-AC06-ABA81AF57B26Q37998002-78A64665-0483-4E8A-B9B2-2440FD05F96EQ38003322-020F7C33-E724-4FBF-8ACA-E1DD478D7A03Q38062284-CE79B0D9-4C01-47AB-A4E9-8C1DDB6400D5Q38560059-6964BB90-EBCC-421D-80AE-87DF5FB0B42DQ38849805-AD6FFD04-AFAE-4414-91F8-3D212560A4D2Q39971724-04A8DD6B-E811-472A-8B64-5FFFEAE07DCDQ41014816-6E0D2D1E-193D-4A6B-8F55-CADB8D05C5F7
P2860
Executive summary: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).
description
2008 nî lūn-bûn
@nan
2008 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
name
Executive summary: American Co ...... tice Guidelines (8th Edition).
@ast
Executive summary: American Co ...... tice Guidelines (8th Edition).
@en
Executive summary: American Co ...... d Clinical Practice Guidelines
@nl
type
label
Executive summary: American Co ...... tice Guidelines (8th Edition).
@ast
Executive summary: American Co ...... tice Guidelines (8th Edition).
@en
Executive summary: American Co ...... d Clinical Practice Guidelines
@nl
prefLabel
Executive summary: American Co ...... tice Guidelines (8th Edition).
@ast
Executive summary: American Co ...... tice Guidelines (8th Edition).
@en
Executive summary: American Co ...... d Clinical Practice Guidelines
@nl
P2093
P356
P1433
P1476
Executive summary: American Co ...... tice Guidelines (8th Edition).
@en
P2093
Gregory W Albers
Holger J Schünemann
Jack Hirsh
P304
P356
10.1378/CHEST.08-0693
P407
P433
P577
2008-06-01T00:00:00Z